Neurology News

SEATTLE – Inebilizumab was shown to be safe and effective in preventing relapses in individuals with neuromyelitis optica spectrum disorder, a speaker said at the 2022 American Academy of Neurology annual meeting.

Representation of individuals underrepresented in academic medicine is further away from reflecting the U.S. population today than it was in 2000, according to findings published in The New England Journal of Medicine.

SEATTLE — MRI biomarkers were significantly associated with glial tau pathology and could aid in the diagnosis of certain neurodegenerative diseases, a presenter said at the 2022 American Academy of Neurology annual meeting.

Women exposed to childhood sexual and emotional abuse had a greater risk for developing multiple sclerosis, according to a prospective cohort study published in the Journal of Neurology, Neurosurgery & Psychiatry.

SEATTLE — Patients with ALS who were treated with CNM-Au8 — a gold nanocrystal suspension — showed improvements in survival, a speaker said at the 2022 American Academy of Neurology annual meeting.

SEATTLE — Fentanyl-related cardiac arrest is associated with worse neurological injury and outcomes compared with cardiac arrest from other opioids, according to a presenter at the 2022 American Academy of Neurology annual meeting.

When it comes to online reviews, physicians should consider online reviews before advertising as reviews not only improve physician visibility online, but also reassure patients about the care they will receive prior to their visit.

SEATTLE — Black patients with MS demonstrated a higher rate of disability throughout their disease course compared with white MS patients, according to a presenter at the 2022 American Academy of Neurology annual meeting.

Boston Scientific Corp. announced it has received FDA approval for its image-guided software for deep brain stimulation therapy in patients with Parkinson’s disease.

SEATTLE — Subtypes of seizures have improved through the use of cenobamate, William E. Rosenfeld, MD, FAAN, said at the 2022 American Academy of Neurology annual meeting.